<?xml version="1.0" encoding="UTF-8"?>
<p>Previous chemical and pharmacological studies on 
 <italic>Iris</italic> sp. indicated that the plants contain several classes of secondary metabolites such as flavonoids, isoflavones, and their glycosides, 
 <italic>C</italic>-glucosylxanthones, quinones, triterpenoids, and stilbene glycosides [
 <xref rid="B12-molecules-25-04588" ref-type="bibr">12</xref>,
 <xref rid="B13-molecules-25-04588" ref-type="bibr">13</xref>,
 <xref rid="B14-molecules-25-04588" ref-type="bibr">14</xref>]. These compounds contribute to the observed immunomodulatory [
 <xref rid="B15-molecules-25-04588" ref-type="bibr">15</xref>,
 <xref rid="B16-molecules-25-04588" ref-type="bibr">16</xref>], estrogenic [
 <xref rid="B17-molecules-25-04588" ref-type="bibr">17</xref>,
 <xref rid="B18-molecules-25-04588" ref-type="bibr">18</xref>], antioxidative [
 <xref rid="B19-molecules-25-04588" ref-type="bibr">19</xref>,
 <xref rid="B20-molecules-25-04588" ref-type="bibr">20</xref>,
 <xref rid="B21-molecules-25-04588" ref-type="bibr">21</xref>], antibacterial [
 <xref rid="B22-molecules-25-04588" ref-type="bibr">22</xref>,
 <xref rid="B23-molecules-25-04588" ref-type="bibr">23</xref>] and anticholinesterase [
 <xref rid="B24-molecules-25-04588" ref-type="bibr">24</xref>], cytotoxic [
 <xref rid="B11-molecules-25-04588" ref-type="bibr">11</xref>,
 <xref rid="B25-molecules-25-04588" ref-type="bibr">25</xref>], and anti-osteoporotic activities [
 <xref rid="B26-molecules-25-04588" ref-type="bibr">26</xref>]. Experimental results indicate a direct correlation between 
 <italic>Iris</italic> phenolic compounds (hydroxycinnamic acids, isoflavones, flavones, xanthones) and their pharmacological activity, especially the antioxidant activity [
 <xref rid="B20-molecules-25-04588" ref-type="bibr">20</xref>,
 <xref rid="B27-molecules-25-04588" ref-type="bibr">27</xref>,
 <xref rid="B28-molecules-25-04588" ref-type="bibr">28</xref>,
 <xref rid="B29-molecules-25-04588" ref-type="bibr">29</xref>].
</p>
